Overall,
the mean Visual Analogue Scale (VAS) of back and leg pain improved significantly (6.0 +/- 3.2 to 1.9 +/- 2.6 and 7.4 +/- 2.6 to 2.5 +/- 2.9, both P < 0.001, respectively), and the Oswestry Disability Index (ODI) also improved significantly (50.6 +/- 19.5 to 27.3 +/- 24.9, P < 0.001) after the operation. Moreover, there were no differences between the groups of spondylolisthesis MLN8237 mw and non-spondylolisthesis, or among the patients with and without screw loosening.\n\nConclusions: There is significant clinical improvement after laminectomy and dynamic stabilization with Dynesys for lumbar spinal stenosis. While there was restriction (<3 degrees) in segmental ROM, Dynesys provides similar radiographic stability and clinical effects regardless of pre-operative spondylolisthesis. (C) 2012 Elsevier B.V. All rights reserved.”
“Lung surfactant is secreted via exocytosis of lamellar bodies from alveolar epithelial type 11 cells. Whether micro-RNAs regulate I-BET-762 datasheet lung surfactant secretion is unknown. Micro-RNA-375 (miR-375) has been shown to be involved in insulin secretion. In this article, we report that the overexpression of miR-375 inhibited lung surfactant secretion. However, miR-1.25a, miR-30a, miR-1, miR-382 and miR-101 did not influence lung surfactant secretion. miR-375 had no effects on surfactant synthesis or
the formation of lamellar bodies. However, miR-375 did abolish the lung surfactant secretagogue-induced disassembly and reassembly of cytoskeleton. Our results suggest that miR-375 regulates surfactant secretion via the reorganization of cytoskeleton. (C) 2009 IUBMB IUBMB Life, 62(1): 78-83, 2010″
“P>Atrial septal defect (ASD) is the one of the most common congenital cardiac diseases. Percutaneous device closure of the ASD has developed as an alternative to traditional surgical GSI-IX clinical trial closure with a similar outcome, decreased surgical trauma, and shorter hospital stay. However, several complications have been reported. We now report
a rare complication of late severe mitral insufficiency (MI) after a successful closure of a secundum ASD with an Amplatzer device. The potential mechanisms may be the continual traction of the oversized mismatched device on the root of the mitral annulus and the insufficient rim to the mitral annulus. The patient was sent for a surgical operation to remove the device, and the defect was closed. No MI was found at the one-year follow-up.\n\n(J Card Surg 2009;24:672-674).”
“OBJECTIVE: Catheter-related infection remains a cause of morbidity in the use of external ventricular drains (EVDs). The aim of this retrospective single-center study was to assess the rate and factors related to ventriculostomy infections in the setting of the published literature.\n\nMETHODS: Patients that underwent EVD placement in a single-center were retrospectively reviewed. Diagnosis, treatment, hospital course, and infection-related data were collected and analyzed in reference to ventriculitis rates.